Regulation of p53 in response to DNA damage
The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
Activation of p53 can occur in response to a number of cellular stresses, including DNA damage, hypoxia and nucleotide deprivation. Several forms of DNA damage have been shown to activate p53, including those generated by ionising radiation (IR), radio-mimetic drugs, ultraviolet light (UV) and chemicals such as methyl methane sulfonate (MMS). Under normal conditions, p53 levels are maintained at a low state by virtue of the extremely short-half life of the polypeptide. In addition to this, p53 normally exists in an largely inactive state that is relatively inefficient at binding to DNA and activating transcription. Activation of p53 in response to DNA damage is associated with a rapid increase in its levels and with an increased ability of p53 to bind DNA and mediate transcriptional activation. This then leads to the activation of a number of genes whose products trigger cell-cycle arrest, apoptosis, or DNA repair. Recent work has suggested that this regulation is brought about largely through DNA damage triggering a series of phosphorylation, de-phosphorylation and acetylation events on the p53 polypeptide. Here, we discuss the nature of these modifications, the enzymes that bring them about, and how changes in p53 modification lead to p53 activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“UV-induced phosphorylation at Serine 15 increased p53 stability and protein level that associated with DNA damage [61].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [61]
In the citing paper
“Under normal conditions, cellular p53 protein levels are very low owing to strict control by its negative regulators MDM2 and MDMX, which promote p53 degradation through ubiquitination.27,28”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [28]
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 4,296
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · cited 2×
“Interaction of Mdm2 with this N-terminal region of p53 has been demonstrated to inhibit the ability of p53 to activate transcription (Momand et al., 1992; Oliner et al., 1993).”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“Initial clues suggesting that ATM may be involved in regulation of p53 in response to DNA damage came from observations that cell cycle checkpoint controls and up-regulation of p53 in response to IR are defective in A-T cells (Kastan et al., 1992; Khanna and Lavin, 1993; Canman et al., 1994).”
BackgroundHistone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884 · cited 1×
“Further support for this idea has been provided by the demonstration that certain histone acetyl-transferase (HAT) enzymes correspond to key transcriptional coactivators, such as CBP/p300 and PCAF (for reviews see Grunstein, 1997; Kouzarides, 1999).”
BackgroundA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785 · cited 1×
“The gene mutated in ataxia-telangiectasia patients was mapped to human chromosome 11q2223, and the gene, termed ATM, has been cloned (Gatti et al., 1988; Savitsky et al., 1995).”
BackgroundActivation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · cited 2×
“Thus, in addition to potentially playing a role in acetylating histones at p53-dependent promoters, CBP/p300 has been shown to be able to acetylate p53 at lysine-373 and lysine-382, whilst PCAF can acetylate p53 at lysine-320 (Gu and Roeder, 1997; Sakaguchi, 1998; Liu et al., 1999).”
BackgroundKo, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344 · cited 4×
“Elevated levels of p21 then inhibit the cyclin E/cdk2 and cyclin A/cdk2 kinases, thus preventing these kinases from promoting cell cycle progression (for review, see Ko and Prives, 1996; Levine, 1997).”
BackgroundInfluential
Research works printed but not linked: 3
- Lakin ND, Hann BC and Jackson SP. . 1999 Oncogene in press.
- Lees-Miller SP, Sakaguchi K, Ullrich SJ, Appella E and Anderson CW. . 1992 Mol. Cell. Biol. 12: 5041–5049. · doi:10.1128/mcb.12.11.5041-5049.1992 · Paper page
- Maltzman W and Czyzyk L. . 1984 Mol. Cell. Biol. 4: 1689–1694. · DOI · Paper page
Cited by
Items 801–900 of 1,000
Metabolic Regulation of Hippocampal Neuroprogenitor Apoptosis After Irradiation
Li, Y.-Q., Koritzinsky, M., & Wong, C. S. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz108 · Cited by 5
Increased qualities and in vitro anticancer effects of ‘Doenjang’ fermented in ‘Onggi’
Lee, J., 임양이, Lee, S., Kim, J.-H., & Park, K. (2020) · Korean Journal of Food Preservation · doi:10.11002/kjfp.2020.27.3.346 · Cited by 5
Genome-Protective Topoisomerase 2a-Dependent G2 Arrest Requires p53 in hTERT-Positive Cancer Cells
Lockwood, N., Martini, S., Lopez-Pardo, A., Deiss, K., Segeren, H. A., Semple, R. K., Collins, I., Repana, D., Cobbaut, M., Soliman, T. N., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-1785 · Cited by 5
“In response to DNA damage, p53 expression is regulated by Ser15 and Ser20 phosphorylation by ATM/ATR and Chk2 respectively (21,26-29).”
BackgroundThe Protective Role of p53 in Ras-Induced Transformation of REF52 Cells
Kopnin, P., Ivanov, A. V., Il`inskaya, G. V., Sablina, A. A., Kopnin, B. P., & Chumakov, P. M. (2003) · Molecular Biology · doi:10.1023/a:1024235310268 · Cited by 5
Yoshino, H., Nawamaki, M., Murakami, K., & Kashiwakura, I. (2019) · World Academy of Sciences Journal · doi:10.3892/wasj.2019.11 · Cited by 5
Mosaic Regulation of Stress Pathways Underlies Senescent Cell HeterogeneityPreprint
Avelar, R. A., Duffield, T., Lagger, C., Krstevska, N., Breuer, M., & de Magalhães, J. P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.03.616489 · Cited by 5
RNF144A-VRK2-G3BP1 axis regulates stress granule assembly
Kim, S. W., Lee, J., Jo, K. W., Jeong, Y.-H., Shin, W. S., & Kim, K. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02460-6 · Cited by 6
“The PCR products were cloned into pNTAP-B (Agilent Technologies, California, USA), pPROEX-Hta (Invitrogen, California, USA), pEGFP-C1 (BD Biosciences, California, USA), pTYB2 (Agilent Technologies, California, USA), and pFLAG-CMV2 (RRID:Addgene_15697) plasmids.”
Ho, K., Lin, Y., Huang, H.-C., Lai, F.-R., Yang, Y., Lai, C.-H., Wen, Y., Hsieh, F.-K., Lee, W.-J., & Chien, M. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103945 · Cited by 4
“5A, right panel). p53 activation in response to DNA damage leads to a rapid increase in its levels, enhancing its DNA-binding ability and transcriptional activity, which subsequently triggers genes involved in cell-cycle arrest, apoptosis, or DNA repair [32].”
Ha, S. E., Kim, M. S., Chung, Y. H., & Park, J. K. (2016) · Animal Cells and Systems · doi:10.1080/19768354.2016.1191542 · Cited by 4
Mina53 catalyzes arginine demethylation of p53 to promote tumor growth
Zhou, L., Yu, L., Song, S., Wang, Y., Zhu, Q., Li, M., Sha, Y., Xu, L., Shu, X., Liao, Q., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115242 · Cited by 4
Peptide and protein chemistry approaches to study the tumor suppressor protein p53
Chatterjee, C., & Singh, S. K. (2022) · Organic & Biomolecular Chemistry · doi:10.1039/d2ob00902a · Cited by 4
Splicing DNA Damage Adaptations for the Management of Cancer Cells
Singh, A. K., Yadav, D., & Malviya, R. (2023) · Current Gene Therapy · doi:10.2174/0115665232258528231018113410 · Cited by 4
Evaluating targeted therapies in older patients with TP53 -mutated AML
Sabile, J. M. G., Swords, R. T., & Tyner, J. W. (2024) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2024.2344057 · Cited by 4
“TP53 is the most frequently mutated gene across allcancer andis associated with multiple different mechanisms of inactivation [1,2]. intact TP53 is critical for induction of apoptosis during treatment with conventional cytotoxic chemotherapy [3,4].”
GENOTOXIC STRESS INDUCED POSTTRANSLATIONAL MODIFICATION OF TRANSCRIPTIONAL ADAPTOR PROTEIN ADA3
John, R., Chand, V., Jaiswal, N., & Nag, A. (2013) · Journal of Proteins and Proteomics · Cited by 4
Lee, J. E. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.561 · Cited by 4
“The most common of these high-risk HPV types are HPV-16 and HPV-18, shown to encode transforming and immortalizing activities in cultured cells (31-35).”
Riede, I. (2012) · Journal of Cell Science & Therapy · doi:10.4172/2157-7013.1000133 · Cited by 4
“One signal should induce, possibly via p53, the repair system [24].”
BackgroundArora, D., & Singh, A. (2017) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-017-0162-9 · Cited by 4
“2000a, b; Prives 1998; Lakin and Jackson 1999; Momand et al.”
BackgroundMethodMartínez-Noël, G., Vieira, V. C., Szajner, P., Lilienthal, E. M., Kramer, R. E., Boyland, K. A., Smith, J. A., & Howley, P. M. (2021) · Virology · doi:10.1016/j.virol.2021.05.006 · Cited by 4
Kuroki, Y., & Agata, K. (2023) · Genes to Cells · doi:10.1111/gtc.13068 · Cited by 4
“However, it is well known that UV exposure induces various cellular damages (Lakin & Jackson, 1999).”
BackgroundMohammed, F. F., Abdelrazik, E. G., Anwar, A., & Abdelgayed, S. S. (2024) · Human & Experimental Toxicology · doi:10.1177/09603271241236900 · Cited by 4
“31 The most common hepatic histopathological alterations were hepatocellular polyploidy, indicated by increased DNA content in nuclei by Fulgen reaction and re fl ected microscopically by increased binucleated hepatocytes, hepatocytomegaly, and karyomegaly.”
Role of p53 and mismatch repair in PhIP-induced perturbations of the cell cycle
Duc, R., & Leong-Morgenthaler, P.-M. (2003) · Journal of Chromatography B · doi:10.1016/j.jchromb.2003.10.051 · Cited by 4
Dimitrio, L., Clairambault, J., & Natalini, R. (2012) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 7
Capriotti, M., Bracchetti, L., Cocci, P., Mazzocchi, V., Fazzini, M., Corvaro, F., & Palermo, F. A. (2025) · Diversity · doi:10.3390/d17060385 · Cited by 4
“…the cellular p53 transcript levels is also confirmed by [44], who observed an upregulation in mussels during the summer. p53 can be activated in case of DNA damage: by binding the DNA it promotes the transcription of a number of genes involved in DNA repair, cell cycle arrest, or apoptosis [45].”
Cellular Senescence in Cancer: Mechanisms, Roles in Tumor Progression, and Therapeutic Implications
Yan, J., Zhang, Y., Mao, G., Yu, J., Zhou, T., & Hao, J. (2025) · MedComm – Oncology · doi:10.1002/mog2.70029 · Cited by 3
Fineberg, D., Moreau, A., Schneider‐Futschik, E. K., & Armstrong, C. W. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00229 · Cited by 3
Li, Z., Song, N., Deng, Y., Zhang, Q., Hu, F., Lu, Y., Chen, J., Xiao, P., Yan, A., Li, J., et al. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102642 · Cited by 3
“Under conditions of DNA damage, p53 is often induced and activated [101].”
A vicious cycle inducer in gastric pathogenesis: implication of Helicobacter pylori
Rajaei, A., Mahdavi, P., Chimehrad, R., Zakeri, M., Sadeghloo, Z., & Mojarad, E. N. (2026) · Archives of Microbiology · doi:10.1007/s00203-025-04662-z · Cited by 3
“DNA damage rapidly activates p53, stimulating target genes involved in cell cycle arrest, DNA repair, apoptosis, and cell senescence (Lakin and Jackson 1999 However, it is important to note that CagA contributes to DSB formation via both dependent and independent mechanisms by inducing a state…”
Tyagi, K., Kumari, R., & Venkatesh, V. (2025) · ChemMedChem · doi:10.1002/cmdc.202400849 · Cited by 3
Li, Y., Wang, L., Li, S., Guo, T.-Q., Guo, X., Yan, P., Chen, Y., Wang, L., & Lu, C. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.07.001 · Cited by 4
Millado, J. B. H., Hamajima, R., Sugiura, W., Makino, S., Kobayashi, M., & Ikeda, M. (2021) · Journal of insect biotechnology and sericology · doi:10.11416/jibs.90.2_021 · Cited by 4
Benjamin, R., Banerjee, A., Wu, X., Geurink, C., Buczek, L., Eames, D., Trimidal, S. G., Pluth, J. M., & Schiller, M. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020593 · Cited by 3
“However, in response to DNA damage, the p53 is activated and drives transcription of factors involved in the apoptosis, cell cycle, DNA repair, and cellular senescence [51,52].”
BackgroundProton implantation into living cells under nonvacuum atmosphere
Okawa, R., Daiko, Y., Obata, A., & Kasuga, T. (2023) · AIP Advances · doi:10.1063/5.0131816 · Cited by 3
Leung, E., Taskina, D., Schwab, N., & Hazrati, L. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1225226 · Cited by 4
“26, two-way ANOVA) on p53 (Lakin and Jackson, 1999) gene expression was observed, with WT rmTBI (p = 0.”
MethodBandyopadhyay, A., & Ghosh, S. K. (2023) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2023.111593 · Cited by 3
Gothwal, S. K., Myung, K., Mattila, P. K., & Barlow, J. H. (2026) · Cancer Cell International · doi:10.1101/2024.08.31.609994 · Cited by 3
“DNA damage and DNA replication-stress induced signaling pathways activate p53 [43].”
BackgroundSoman and VX: different effect on cellular signalling
Pejchal, J., Österreicher, J., Kassa, J., Tichý, A., Šinkorová, Z., Zárybnická, L., Kubelková, K., & Kuča, K. (2012) · Journal of Applied Biomedicine · doi:10.2478/v10136-011-0018-z · Cited by 3
Asperyellone prevents HDF cells from UVB irradiation damages: An elaborated study
Santhakumaran, I., Shanuja, S. K., Narayanaswamy, R., & Gnanamani, A. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28030 · Cited by 4
“On the other hand if the DNA damage is unsuccessful, p53 activates the apoptotic process.(41) In the current study, UVB irradiated cells showed damaged DNA with tail and the nucleoids are not intact, whereas, in untreated cells there was no tail formation and the nucleoids are intact as shown in Figure 5A.”
BackgroundActivation of p53 in anoxic freshwater crayfish, Faxonius virilis
Gupta, A., Breedon, S. A., & Storey, K. B. (2022) · Journal of Experimental Biology · doi:10.1242/jeb.244145 · Cited by 4
Degradation-driven protein level oscillation in the yeast Saccharomyces cerevisiae
Mahrou, B., Pirhanov, A., Alijanvand, M. H., Cho, Y. K., & Shin, Y.-J. (2021) · Biosystems · doi:10.1016/j.biosystems.2022.104717 · Cited by 3
Construction of a Reporter System for Fine Assessment of the p53 Activity in Cultured Cells
Strunina, S. M., Ivanov, A. V., & Chumakov, P. M. (2003) · Molecular Biology · doi:10.1023/b:mbil.0000008354.57245.70 · Cited by 3
“These are various DNA lesions [14], disturbance of the tubulin cytoskeleton [15] and actin fibrils [16], generation of polyploid cells [17], RNA synthesis arrest [18], oxidative CELL MOLECULAR BIOLOGY”
BackgroundNomura, J., HIMEDA, J., Chen, Z., Sugaya, S., TAKAHASHI, S., Kita, K., Ichinose, M., & Suzuki, N. (2002) · Journal of Radiation Research · doi:10.1269/jrr.43.s251 · Cited by 3
GRAS1 non-coding RNA protects against DNA damage and cell death by binding and stabilizing NKAPPreprint
Su, T., Trang, N., Zhu, J., Kong, L., Cheung, D., Chou, V., Ellis, L., Huang, C., Camden, N., & McHugh, C. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.20.545783 · Cited by 3
ANGEL2 Modulates Wild-type TP53 Translation and Doxorubicin Chemosensitivity in Colon Cancer
Lucchesi, C. A., Mantrala, S., Tran, D., Batra, N., Durve, A., Suen, C., Zhang, J., Ghosh, P., & Chen, X. (2025) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-24-0702 · Cited by 2
Putra, M. A., Sandora, N., Soetisna, T. W., Kusuma, T. R., Fitria, N. A., Karimah, B., Noviana, D., Gunanti, G., Busro, P. W., Supomo, S., et al. (2025) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-025-03453-3 · Cited by 2
“…and serves as a tumor suppressor by modulating the cell cycle, preventing unchecked proliferation, and maintaining genomic integrity [86]. p53 also activates p21, a cyclin-dependent kinase inhibitor that orchestrates cell cycle arrest and transcriptional regulation. p21 plays a dual…”
Tolotto, V., Gualandi, N., Cortolezzis, Y., Picco, R., Colitti, M., D’Este, F., Gani, M., Hancock, W. W., Terrosu, G., Degrassi, C., et al. (2025) · Molecular Oncology · doi:10.1002/1878-0261.70152 · Cited by 3
“OXPT treatment led to elevated p53 protein levels, consistent with its activation [87], and this effect was observed equally in both the absence and presence of DOX-induced FBXW7 expression (Fig.”
Kwon, Y., Yoon, H., Han, J., Park, J. W., & Jang, K. L. (2026) · FEBS Letters · doi:10.1002/1873-3468.70275 · Cited by 2
“This phosphorylation disrupts the MDM2-p53 complex, stabilizing p53 by preventing MDM2-mediated proteasomal degradation [2,5,6].”
Ganguly, A. A., & Chen, Z. (2016) · Springer eBooks · doi:10.1007/978-3-319-19674-9_28 · Cited by 3
Yamaguchi, Y., Fukunaga, Y., Takagi, M., Saito, T., Tamura, K., & Hoshiya, T. (2021) · Journal of Toxicologic Pathology · doi:10.1293/tox.2020-0070 · Cited by 2
Modeling of Apoptotic p53 Protein Pathway for Damaged DNA
Patra, T., Chatterjee, S., & Barman, S. (2022) · Lecture notes in electrical engineering · doi:10.1007/978-981-16-9154-6_44 · Cited by 2
Legartová, S., Fagherazzi, P., Goswami, P., Brázda, V., Lochmanová, G., Koutná, I., & Bártová, E. (2022) · Biochimie · doi:10.1016/j.biochi.2022.09.013 · Cited by 2
Luo, L., Liu, H., & Yan, F. (2022) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2023109 · Cited by 3
“However, the concentration of P53 reaches a higher level when subjected to greater stimulation, which in turn induces cell apoptosis [16, 17].”
BackgroundMethodvan der Put, A. G., Trtková, K. S., & Škarda, J. (2025) · Neoplasma · doi:10.4149/neo_2024_240925n403 · Cited by 2
Cancer-associated transporters: Molecular drivers and drug delivery gateways
Khan, A. A., Biswas, S., Garg, M., & Sengupta, S. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117376 · Cited by 3
Functional Analysis of Chromodomain Helicase DNA Binding Protein 2(CHD2) mediated Genomic Stability
Rajagopalan, S. (2010) · Cited by 2
D,L-Methadon erhöht den zytotoxischen Effekt konventioneller Krebstherapien
Friesen, C. (2017) · Deutsche Zeitschrift für Onkologie · doi:10.1055/s-0043-110160 · Cited by 2
“Des Weiteren haben zellzyklusregulierende Gene wie das p53-Gen eine große Bedeutung bei der Apoptose und der Induktion des DNA-Schadens [32, 40, 41].”
Backgroundp53 and Vascular Dysfunction: MicroRNA in Endothelial Cells
Yamakuchi, M., Panta, S., & Hashiguchi, T. (2018) · InTech eBooks · doi:10.5772/intechopen.75461 · Cited by 3
“Although the expression of p53 is in lower level during normal condition, upon activation, p53 increases its level along with the increase of its half-life [8] and gets translocated to the nucleus [9].”
BackgroundThe role of time delays in P53 gene regulatory network stimulated by growth factor
Dai, C., Liu, H., & Yan, F. (2020) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2020213 · Cited by 2
Novel p53-Based Therapies: Strategies and Future Prospects
Laín, S., & Lane, D. P. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_16 · Cited by 3
p53 SUMOylation promotes neurogenesis defects in APP/PS1 mice
Yin, A., Gui, Y., Wan, L., Cai, Q., Luo, Y., Wang, J., Liu, R., Ying, C., Wang, X., & Yang, F. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251340432 · Cited by 1
Khan, Z., Gomatam, A., Murty, U. S., & Dixit, V. A. (2025) · Mammalian Genome · doi:10.1007/s00335-025-10134-y · Cited by 1
“…2021) DNA damage causes p53 to become active, and it activates genes that regulate various cell responses by acting as a transcription factor (Lakin and Jackson 1999) Furthermore, several p53-regulated genes aid in DNA repair, communicate with neighboring cells, or establish feedback loops…”
Caliban is a transcriptional target of p53 in response to DNA damage
Cui, J., Zhang, H., Cheng, Y., Bi, X., & Li, D. (2025) · PLoS ONE · doi:10.1371/journal.pone.0331141 · Cited by 1
Wang, Q., Sun, X., Han, X., Zhang, X., Wang, W., Wang, H., Ren, H., & Gu, L. (2026) · MedComm – Oncology · doi:10.1002/mog2.70054 · Cited by 2
Zhang, M.-Y., Sun, R.-Q., Min, Q., Zhu, Y.-Q., Qin, S.-K., & Guo, Q.-L. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.v32.i6.113529 · Cited by 2
“The level of p53 protein in cells is extremely low under normal conditions as a result of the strict regulation of negative regulatory factors MDM2 and MDM4, which promote p53 degradation through ubiquitination[27,28].”
Kieu, T. T. T., Sim, H., Bhattarai, G., So, H.-S., Lee, J., & Kook, S. (2026) · Environmental Science & Technology · doi:10.1021/acs.est.5c08365 · Cited by 1
Quadreli, D. H., Sakai, A. H., Martins, S. H., Bomfim, L. P., Kawasaki, J., Bertozzi, M. M., Colodro, I. M., Verri, W. A., Jr., Serpeloni, J. M., & Fernandes, G. S. A. (2026) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2026.117823 · Cited by 1
Biology of p53 protein isoforms and their significance in hematological malignancies
Janik, A. M., Tracz‐Gaszewska, Z., Misiewicz-Krzemińska, I., & Jamroziak, K. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1854189 · Cited by 1
“Furthermore, p53 activity is tightly regulated by post-translational modi fi cations and interactions with various proteins, enabling a fi nely tuned response tailored to the type and severity of stress (47).”
Modeling the effect of p53 on tumor heterogeneity and the mutator phenotype
Ryan, M. K., Berryman, M. J., & Abbott, D. (2005) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.602423 · Cited by 1
“Such forms of DNA damage that have been shown to activate p53 include those caused by ultraviolet (UV) light, other ionizing radiation, and exposure to radio-mimetic drugs.(11) Activation of p53 in response to DNA damage increases the ability of the p53 protein to bind to DNA(11) and causes a decrease in its affinity…”
BackgroundTrimidox-Induced Apoptosis Is Mediated Through Induction of p53 in NALM-6 Cells
Kanno, S., Ohtake, T., Osanai, Y., Kurauchi, K., Ujibe, M., Uwai, K., Takeshita, M., Satoh, S., & Ishikawa, M. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.sc0070384 · Cited by 1
System Biology Approach to Study Cancer Related Pathways
Guo, Y., & Yang, X. (2012) · Springer eBooks · doi:10.1007/978-94-007-4819-4_2 · Cited by 2
Protection of Pifithrin-α and Melatonin against Doxorubicin-Induced Cardiotoxicity.
Liu, X. (2003) · Digital Commons - East Tennessee State University (East Tennessee State University) · Cited by 3
Quantitative analysis of gene expression changes in response to genotoxic compounds
Morris, C. A., El-Hiti, G. A.-R., Weeks, I., Woodhead, J. S., Smith, K., & Kille, P. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.11.004 · Cited by 1
“These include The mechanism of TP53 activation is well established as being post-translational ( Lakin and Jackson, 1999 ).”
Keratinocyte Stem Cells: Role in Aging
Ansary, T. M., Kamiya, K., & Ohtsuki, M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102805 · Cited by 1
Yamaguchi, Y., Saito, T., Takagi, M., Nakazawa, T., & Tamura, K. (2022) · Journal of Toxicologic Pathology · doi:10.1293/tox.2022-0003 · Cited by 1
Dong, Y., Sun, D., Li, J., Ye, S., & Zhu, Y. (2022) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.spl.501 · Cited by 1
“TP53 is the gene with the highest correlation with cancer among known tumor suppressor genes[19].”
BackgroundSuárez, M. F., Itakura, T., Pany, S., Jeong, S., Chintala, S. K., Raizman, M. B., Riesinger, S. W., Lazarova, T. I., Echenique, J., Serra, H. M., et al. (2023) · Stresses · doi:10.3390/stresses3030044 · Cited by 1
“Activation of TP53 can occur in response to a number of cellular stresses, including DNA damage [72].”
BackgroundYoon, H., & Jang, K. L. (2023) · Cells · doi:10.3390/cells13010062 · Cited by 1
“As it is relatively well established that p53 is promptly activated in response to DNA damage induced by ROS [30,31], it is interesting to explore whether ROS, such as H 2 O 2 , inhibit HCV replication by promoting the proteasomal degradation of HCV Core mediated by E6AP.”
BackgroundNurcahyanti, A. D. R., Tenia, T. F., & Chandra, F. (2024) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v8i1.9 · Cited by 1
Identification and characterization of a novel upstream promoter of zebrafish p53 gene
Tian, X., Zhu, Z., Li, W., Zhang, J., & Han, B. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-10112-8 · Cited by 1
“WT p53 rapidly accumulates after DNA damage and induces cell cycle arrest and apoptosis [16, 17].”
Bioinformatic Analysis of Actin-Binding Proteins in the Nucleolus During Heat Shock
Taniguchi, S., Torii, T., Goto, T., Takeuchi, K., Katsumi, R., Sumida, M., Lee, S., Sugimoto, W., Gessho, M., Itoh, K., et al. (2024) · Genes · doi:10.3390/genes15121580 · Cited by 1
Interaction Between Viral Proteins and Caretakers — Polyomavirus as a Model
Huang, J.-L., & Lin, C. (2015) · InTech eBooks · doi:10.5772/59661 · Cited by 1
“The expression level and transcriptional activity of p53 are increased [59].”
BackgroundClinically relevant ex vivo fatty acid profiles from a lipid model for colorectal adenocarcinoma
Nel, A. (2007) · Cited by 1
Non-Mutated Mediator Genes in Diverse Epithelial Cancer Types
Walters, E., & McMurray, H. R. (2017) · UR Research (University of Rochester) · Cited by 1
The Role of Pirh2 E3 Ligases in Ubiquitination and p73 Regulation
Abou Zeinab, R. M. (2015) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3610vx4f · Cited by 1
de Oliveira, B. P. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.76.2021.tde-03092021-115103 · Cited by 4
Valentin, J. (2005) · Annals of the ICRP · doi:10.1016/j.icrp.2005.11.003 · Cited by 1
Data from Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer
Durinikova, E., Reilly, N. M., Buzo, K., Mariella, E., Chilà, R., Lorenzato, A., Dias, J. M. L., Grasso, G., Pisati, F., Lamba, S., et al. (2023) · doi:10.1158/1078-0432.c.6532661 · Cited by 1
Abualshroud, A., Abdon, F., Elamin, A. A. E., Elgenaidi, A., Mustafa, A. B., & Sami, M. M. (2026) · Research Square · doi:10.21203/rs.3.rs-8432900/v1 · Cited by 1
Mechanisms and Biological Markers of Carcinogenesis
Santella, R. M. (2002) · Springer eBooks · doi:10.1007/0-387-21605-7_2 · Cited by 1
“The p53 tumor suppressor gene is probably the most extensively studied gene and is mutated in about 50% of various human tumors [reviewed in [70,71]].”
BackgroundG2 Phase Cell Cycle Regulation by E2F4 Following Genotoxic Stress
Crosby, M. E. (2006) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
In vitro models for investigating keratinocyte responses to ultraviolet B radiation
Fernandez, T. L. (2013)
Transferência gênica de p19Arf e interferon-b em células de melanoma.
Ribeiro, A. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.87.2011.tde-10022012-143841 · Cited by 1
Toxicogenomic responses to N-Nitroso compound exposure in relation to human colorectal cancer risk
Hebels, D. G. A. J. (2010) · Research Publications (Maastricht University) · doi:10.26481/dis.20101216dh
A novel phosphatase modulating the DNA damage response and the tumor suppressor p53
Marinoglou, K. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3254
Evaluation of the primary mouse hepatocyte model for the prediction of genotoxicity
Mathijs, K. (2009) · Research Publications (Maastricht University) · doi:10.26481/dis.20091209km
E2F1 induction following DNA damage and oncogene activation
Helgason, G. V. (2007) · Enlighten: Theses (The University of Glasgow)
Structural and functional interrogation of Anterior Gradient-2
Gray, T. A. (2013) · ERA
Dissecting the Interaction between p53 and TRIM24
Duncan, A. D. (2011) · Digital Commons-TMC (Texas Medical Center)
Vilar, J. B. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2014.tde-24022015-105346
Aktaş, S., Altun, Z. S., Erbayraktar, Z., & Olgun, N. (2010) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2008-10373
Metadata
- Authors
- Lakin, N. D., & Jackson, S. P.
- Affiliations
- University of Cambridge (GB)
- ORCID
- Jackson, Stephen P
- Venue
- Oncogene
- Published
- 1999-12-13
- Volume
- 18
- Issue
- 53
- Pages
- 7644-7655
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2007935491
- Cited by
- 987
- References
- 128
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 30 · 2023: 54 · 2022: 57 · 2021: 46 · 2020: 46 · 2019: 33 · 2018: 40 · 2017: 43 · 2016: 34 · 2015: 33 · 2014: 28 · 2013: 23 · 2012: 28
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, DNA damage response, p53 activation, post-translational modification, phosphorylation, dephosphorylation, acetylation, ionizing radiation, ultraviolet radiation, methyl methanesulfonate, cell cycle arrest, apoptosis, DNA repair, transcriptional activation, hypoxia
- MeSH terms
- Adenosine Triphosphatases, Animals, DNA Damage, DNA Helicases, DNA-Binding Proteins, Humans, Nuclear Proteins, Protein Processing, Post-Translational, Proto-Oncogene Proteins, Signal Transduction, Trans-Activators, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Tumor Suppressor Proteins, Saccharomyces cerevisiae Proteins, Proto-Oncogene Proteins c-mdm2, DNA-Activated Protein Kinase, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.